Exchange: NASDAQ·Updated 05:30 AM EDT
ALDX logo

ALDX Aldeyra Therapeutics Inc

$1.52
$0.035
(2.36%)
Pre-Market
Prev Close $1.49
EarningsNov 4
Mkt Cap$89.58M
Vol584.00

About ALDX

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities related to general business planning, including raising capital. It focuses on the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
66

Bullish Sentiment

How do you feel about ALDX?

Advertisement|Remove ads.